NSAV Holding Inc (NSAV)

[Panchoranchos]

Why E-Lilly hasn't reported this agreement with VSRI?
A similar agreement was reported by
https://www.lilly.com/newsroom
but to a different company
https://investor.lilly.com/releasedetail.cfm?ReleaseID=1051851
INDIANAPOLIS and ATLANTA, Dec. 14, 2017 /PRNewswire/ -- Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, and Eli Lilly and Company (NYSE: LLY), a leader in diabetes care for more than 90 years, are coming together to develop provider-focused tools that will integrate personalized solutions for people who use insulin to manage their diabetes, the companies announced today.
About Rimidi
Rimidi is an Atlanta-based, woman-led digital health company bringing to market data analytics and disease management solutions.